Clinical Trial

Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD

Study acronym: Senergy-CKD
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Skeletal muscle metabolic health is critical for mobility and an underrecognized target of metabolic acidosis in chronic kidney disease. Impaired muscle mitochondrial metabolism underlies poor physical endurance increasing the risk of mobility disability. The proposed project will use precise in vivo tools to study the pathophysiology of poor physical endurance in a clinical trial treating metabolic acidosis among persons living with chronic kidney disease.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2021-07-20; most recent amendment 2026-05-04.
Status change: Not Yet Recruiting → Recruiting 2023-03-14
Trial Details
NCT Number NCT04984226
Lead Sponsor University of California, Davis
Collaborators: Vanderbilt University Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Chronic Kidney Diseases, Metabolic Acidosis, Fatigue, Physical Endurance, Insulin Resistance, Mitochondrial Energetics, Diabetes
Enrollment 80 participants
Start Date 2023-09-08
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-06